NBTY, Inc.   Report issue

For profit
Founded: Ronkonkoma NY United States (1971)
Status: No NME R&D (1971)

Organization Overview

First Clinical Trial
2008
NCT01873820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

caffeine (1 trial)

vitamin c (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 2